Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO Trial.
暂无分享，去创建一个
M. Bernard | M. Béné | L. Fornecker | C. Récher | N. Ifrah | P. Cornillet‐Lefèbvre | J. Delaunay | N. Vey | L. Salmi | I. Luquet | E. Delabesse | E. Jourdan | A. Pigneux | A. Banos | M. Hunault | J. Asselineau | J. Cahn | P. Dumas | C. Bonmati | J. Ianotto | R. Guiéze | M. Ojeda-Uribe | H. Zerazhi | R. Delépine | Yosr Hishri | Ariane C. Mineur | R. Guièze | Ariane C Mineur